Related Experiment Video
Updated: Mar 1, 2026

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors
Published on: September 20, 2016
Somatic Mutations Drive Distinct Imaging Phenotypes in Lung Cancer
Emmanuel Rios Velazquez1, Chintan Parmar1, Ying Liu2,3
1Department of Radiation Oncology Dana-Farber Cancer Institute, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.
Radiomics, an artificial intelligence approach, successfully links radiographic phenotypes to specific tumor mutations in lung adenocarcinoma. This AI-driven imaging analysis can predict tumor genotypes, offering potential for noninvasive, low-cost biomarkers.
Area of Science:
- Oncology
- Radiology
- Artificial Intelligence
- Genomics
Background:
- Somatic mutations drive tumor development and phenotype.
- Radiographic phenotypes are typically disconnected from specific mutations.
- Artificial intelligence, specifically radiomics, quantifies imaging phenotypes.
Purpose of the Study:
- To connect imaging phenotypes with somatic mutations in lung adenocarcinoma.
- To develop and validate radiomic signatures for predicting tumor genotypes.
- To assess the performance of radiomic signatures against conventional predictors.
Main Methods:
- Integrated analysis of independent datasets (763 lung adenocarcinoma patients).
- Somatic mutation testing and engineered CT image analytics.
- Development and validation of radiomic signatures in discovery and validation cohorts.
Main Results:
- Radiomic signatures outperformed conventional radiographic predictors.
- A signature for radiographic heterogeneity distinguished EGFR+ from EGFR- cases (AUC=0.69).
- A signature distinguished EGFR+ from KRAS+ tumors (AUC=0.80), improving prediction when combined with clinical models (AUC=0.86).
Conclusions:
- Somatic mutations drive distinct radiographic phenotypes predictable by radiomics.
- Radiomics can serve as noninvasive, low-cost imaging biomarkers.
- This approach has significant clinical implications for personalized medicine.
More Related Videos
06:51Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer
Published on: July 21, 2018
07:59Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer
Published on: September 8, 2023
Related Concept Videos
Cancers Originate from Somatic Mutations in a Single Cell
Cancer